We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Quest Diagnostics Inc. 2.03% $17.43B ...

A protocol for differentiating visceral sensory ganglion organoids from induced pluripotent stem cells allows the establishment of an in vitro model for the gut–visceral nerve–brain axis and ...

Hold Dr Reddyu2019s Laboratories; target of Rs 1270: ICICI Securities Nov 06 2024 01:35 PM Sell Dr Reddy's; target of Rs 1070: Emkay Global Financial Nov 06 2024 01:19 PM ...

However, limited product launches in the US and an elevated selling, general, and administrative (SG&A) costs mean no near-term catalysts, Jefferies noted. Citi maintains a 'Sell' rating on Dr Reddy's ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

November 07, 2024 General Catalyst to buy Ohio system for $485M | 21 systems naming rev cycle VPs | Hospitals' chronic payment problem | What Trump's win might mean for MA | 7 prior auth updates ...